Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-033639

EVP, Chief R&D Officer sold 3,281 shares at $53.85 ($176,682)

From the SEC's structured data for this filing

Trades in this filing

Friberg Gregory R · EVP, Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-07 Sale : show line 1 in the form −3,281 $53.85 $176,682 51,818 D
Open-market sales · 3,281 sh · avg $53.85 · $176,682
Loading xslF345X06/wk-form4_1778533271.xml…